tiprankstipranks
Sangamo gets FDA clearance of IND application for ST-503 in iSFN
PremiumThe FlySangamo gets FDA clearance of IND application for ST-503 in iSFN
1M ago
Sangamo up 11% at $2.17 on FDA clearing IND for ST-503
Premium
The Fly
Sangamo up 11% at $2.17 on FDA clearing IND for ST-503
1M ago
Sangamo price target raised to $3 from $1 at Wells Fargo
Premium
The Fly
Sangamo price target raised to $3 from $1 at Wells Fargo
1M ago
Sangamo reports Q3 EPS 4c, consensus (3c)
PremiumThe FlySangamo reports Q3 EPS 4c, consensus (3c)
1M ago
Sangamo options imply 21.0% move in share price post-earnings
Premium
The Fly
Sangamo options imply 21.0% move in share price post-earnings
1M ago
Sangamo price target raised to $10 from $5 at H.C. Wainwright
Premium
The Fly
Sangamo price target raised to $10 from $5 at H.C. Wainwright
2M ago
Unusually active option classes on open October 22nd
PremiumThe FlyUnusually active option classes on open October 22nd
2M ago
Sangamo announces alignment with FDA on ST-920 accelerated approval pathway
Premium
The Fly
Sangamo announces alignment with FDA on ST-920 accelerated approval pathway
2M ago
Sangamo Therapeutics Seeks Court Approval for Stock Amendment
Premium
Company Announcements
Sangamo Therapeutics Seeks Court Approval for Stock Amendment
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100